Ventas (VTR) Stock Forecast & Price Target

Q: What analysts cover Ventas?

Ventas has been rated by research analysts at Barclays , BMO Capital Markets , Citigroup , Deutsche Bank Aktiengesellschaft , Evercore , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Mizuho , Raymond James Financial , Royal Bank Of Canada , Scotiabank , The Goldman Sachs Group , UBS Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$97.18 -0.45 (-0.46%)

Closing price 03:59 PM Eastern

Extended Trading

$97.42 +0.25 (+0.26%)

As of 07:43 PM Eastern

Compare

Ventas - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
5

Buy
14

Based on 19 Wall Street analysts who have issued ratings for Ventas in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 5 have given a hold rating, and 14 have given a buy rating for VTR.

Consensus Price Target

$96.50
-0.69% Downside

According to the 19 analysts' twelve-month price targets for Ventas, the average price target is $96.50. The highest price target for VTR is $110.00, while the lowest price target for VTR is $88.00. The average price target represents a forecasted downside of -0.69% from the current price of $97.18.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for VTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ventas and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTR Analyst Ratings Over Time

Type	Current Forecast 7/22/25 to 7/22/26	1 Month Ago 6/22/25 to 6/22/26	3 Months Ago 4/23/25 to 4/23/26	1 Year Ago 7/22/24 to 7/22/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	14 Buy rating(s)	15 Buy rating(s)	13 Buy rating(s)	8 Buy rating(s)
Hold	5 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$96.50	$96.00	$90.47	$72.90
Forecasted Upside	-0.69% Downside	15.80% Upside	9.02% Upside	8.60% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

VTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ventas Stock vs. The Competition

Type	Ventas	Finance Companies	Broader Market
Consensus Rating Score	2.74	2.32	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-0.69% Downside	29.86% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent VTR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/8/2026	Weiss Ratings 5 of 5 stars		Downgrade	Buy (B-) ➝ Hold (C+)
7/7/2026	Barclays 3 of 5 stars	Richard Hightower 3 of 5 stars	Initiated Coverage	Overweight ➝ Equal Weight	$99.00	+7.40%
6/18/2026	Scotiabank 4 of 5 stars	Nicholas Yulico 3 of 5 stars	Lower Target	Sector Perform	$95.00 ➝ $88.00	+8.12%
6/16/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rodgers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$94.00	+12.11%
6/16/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$100.00	+19.88%
6/1/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kilichowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$93.00 ➝ $96.00	+16.40%
5/22/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$98.00	+11.28%
5/19/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$110.00	+24.82%
5/12/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Petersen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$97.00 ➝ $100.00	+12.85%
5/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Mueller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$93.00 ➝ $94.00	+7.60%
America’s answer to universal basic income (Ad) Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income Plan - direct ownership in 14 entities controlling U.S. pipelines, terminals, and processing plants, targeting 10% annually. The plan issues 42 payouts per year and is on pace to distribute $53 billion in 2025 - a record. The next distribution drops in days. See how to enroll in the Patriot Income Plan before the next payout
5/7/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Todd M. Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$90.00 ➝ $95.00	+11.10%
5/4/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$100.00	+13.49%
5/4/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$91.00 ➝ $98.00	+11.23%
5/4/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$85.00 ➝ $93.00	+5.55%
5/1/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$96.00 ➝ $100.00	+13.56%
4/29/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$95.00	+8.90%
2/13/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$90.00	+5.70%
2/10/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Ferguson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$88.00	+5.52%
2/9/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$93.00	+12.40%
2/14/2025	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$69.00 ➝ $78.00	+18.10%
1/17/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rodgers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$66.00 ➝ $65.00	+11.31%
8/9/2024	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Rosivach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:45 PM ET.

Should I Buy Ventas Stock? VTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, July 19, 2026. Please send any questions or comments about these Ventas pros and cons to contact@marketbeat.com.

Ventas
Bull Case

Here are some ways that investors could benefit from investing in Ventas, Inc.:

The company reported a significant revenue increase of 22.0% year-over-year, indicating strong growth potential in the healthcare real estate sector.
Ventas, Inc. has set its FY 2026 earnings per share (EPS) guidance at 3.820-3.890, suggesting a stable outlook for profitability.
The current stock price is around $30, which may present an attractive entry point for investors looking for value in the REIT sector.
With a recent quarterly dividend of $0.52 per share, Ventas, Inc. offers a dividend yield of 2.3%, providing income to investors.
The company operates a diversified portfolio of healthcare-related properties, which can mitigate risks associated with market fluctuations in specific sectors.

Ventas
Bear Case

Investors should be bearish about investing in Ventas, Inc. for these reasons:

The dividend payout ratio is currently very high at 378.18%, which may raise concerns about the sustainability of future dividends.
Despite revenue growth, the net margin is relatively low at 4.25%, indicating potential challenges in profitability management.
The return on equity is only 2.09%, suggesting that the company may not be effectively utilizing its equity to generate profits.
As a real estate investment trust (REIT), Ventas, Inc. is subject to market risks associated with the real estate sector, which can be volatile.
Investors may face uncertainty regarding the long-term impacts of economic conditions on the healthcare real estate market, which could affect future performance.

VTR Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Ventas is $96.50, with a high forecast of $110.00 and a low forecast of $88.00.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last year. There are currently 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VTR shares.

According to analysts, Ventas's stock has a predicted downside of -0.69% based on their 12-month stock forecasts.

Over the previous 90 days, Ventas's stock had 1 upgrade and 1 downgrade by analysts.

Ventas has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Raymond James Financial, Royal Bank Of Canada, Scotiabank, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Ventas more than other "finance" companies. The consensus rating for Ventas is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how VTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Ventas Recommendations

This page (NYSE:VTR) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ventas (VTR) Stock Forecast & Price Target